Matches in SemOpenAlex for { <https://semopenalex.org/work/W2388218074> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W2388218074 abstract "Objective To investigate whether the patients with chronic hepatitis B(CHB) could be maintained with negative HBV DNA and reduce the risk of lamivudine(LAM) resistance after the active replacement of LAM to Adefovir dipivoxil(ADV) before the occurrence of virological breakthrough.Methods Patients who had obtained virological response(i.e.,the serum HBV DNA was under the lower limit of detection) and biochemical response(i.e.normalization of serum ALT) after 36 weeks of LAM monotherapy were randomly divided into group A(observation group) and group B(control group).Patients in A group were overlapped with LAM and ADV for twelve weeks before the ADV monotherapy and patients in B group were added ADV only after the occurrence of virological breakthrough with LAM monotherapy.The virological and biochemical responses were evaluated at 48,72,and 96 weeks during the antiviral therapy.Results The rate of negative HBV DNA was 100%(31/31),100%(31/31) and 96.8%(30/31) in A group,and 90.0%(27/30),80.0%(24/30) and 73.3%(22/30) in B group at week 48,72,and 96.The difference was significant between week 72 and 96.The rate of normalization of liver function was 100%(31/31),100%(31/31) and 100%(31/31) in A group,and 93.3%(28/30),90.0%(27/30) and 80.0%(24/30) in B group at week 48,72,and 96,respectively.The difference was significant at week 96 between the two groups.No severe adverse events were found in the two groups during the therapy.Conclusion Active replacement of LAM to ADV during the treatment of patients with CHB can keep the high rate of HBV DNA negative and normalization of biochemical index,and this remedy may be more suitable for patients with CHB in poor financial condition." @default.
- W2388218074 created "2016-06-24" @default.
- W2388218074 creator A5038028519 @default.
- W2388218074 date "2011-01-01" @default.
- W2388218074 modified "2023-09-26" @default.
- W2388218074 title "Maintenance of negative HBV DNA in patients with chronic hepatitis B during 96 weeks followup with active replacement of Adefovir dipivoxil with Lamivudine" @default.
- W2388218074 hasPublicationYear "2011" @default.
- W2388218074 type Work @default.
- W2388218074 sameAs 2388218074 @default.
- W2388218074 citedByCount "0" @default.
- W2388218074 crossrefType "journal-article" @default.
- W2388218074 hasAuthorship W2388218074A5038028519 @default.
- W2388218074 hasConcept C126322002 @default.
- W2388218074 hasConcept C197934379 @default.
- W2388218074 hasConcept C203014093 @default.
- W2388218074 hasConcept C2522874641 @default.
- W2388218074 hasConcept C2777382497 @default.
- W2388218074 hasConcept C2777785397 @default.
- W2388218074 hasConcept C2777869810 @default.
- W2388218074 hasConcept C2779517838 @default.
- W2388218074 hasConcept C2780593183 @default.
- W2388218074 hasConcept C2992208098 @default.
- W2388218074 hasConcept C71924100 @default.
- W2388218074 hasConcept C90924648 @default.
- W2388218074 hasConceptScore W2388218074C126322002 @default.
- W2388218074 hasConceptScore W2388218074C197934379 @default.
- W2388218074 hasConceptScore W2388218074C203014093 @default.
- W2388218074 hasConceptScore W2388218074C2522874641 @default.
- W2388218074 hasConceptScore W2388218074C2777382497 @default.
- W2388218074 hasConceptScore W2388218074C2777785397 @default.
- W2388218074 hasConceptScore W2388218074C2777869810 @default.
- W2388218074 hasConceptScore W2388218074C2779517838 @default.
- W2388218074 hasConceptScore W2388218074C2780593183 @default.
- W2388218074 hasConceptScore W2388218074C2992208098 @default.
- W2388218074 hasConceptScore W2388218074C71924100 @default.
- W2388218074 hasConceptScore W2388218074C90924648 @default.
- W2388218074 hasLocation W23882180741 @default.
- W2388218074 hasOpenAccess W2388218074 @default.
- W2388218074 hasPrimaryLocation W23882180741 @default.
- W2388218074 hasRelatedWork W1988549760 @default.
- W2388218074 hasRelatedWork W2023509812 @default.
- W2388218074 hasRelatedWork W2096944087 @default.
- W2388218074 hasRelatedWork W2106641526 @default.
- W2388218074 hasRelatedWork W2348710885 @default.
- W2388218074 hasRelatedWork W2348773495 @default.
- W2388218074 hasRelatedWork W2349642934 @default.
- W2388218074 hasRelatedWork W2350055268 @default.
- W2388218074 hasRelatedWork W2354100550 @default.
- W2388218074 hasRelatedWork W2359732956 @default.
- W2388218074 hasRelatedWork W2362330741 @default.
- W2388218074 hasRelatedWork W2363757513 @default.
- W2388218074 hasRelatedWork W2366294606 @default.
- W2388218074 hasRelatedWork W2371804212 @default.
- W2388218074 hasRelatedWork W2373688285 @default.
- W2388218074 hasRelatedWork W2389856427 @default.
- W2388218074 hasRelatedWork W2998172320 @default.
- W2388218074 hasRelatedWork W3029479021 @default.
- W2388218074 hasRelatedWork W3030624611 @default.
- W2388218074 hasRelatedWork W3160679911 @default.
- W2388218074 isParatext "false" @default.
- W2388218074 isRetracted "false" @default.
- W2388218074 magId "2388218074" @default.
- W2388218074 workType "article" @default.